By Bhanvi Satija and Puyaan Singh Nov 12 (Reuters) - The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, raising questions about its future in the market. The drug, Ocaliva, will continue to be available in the U.S. under the accelerated approval status, the company said. Under the accelerated pathway, the FDA...

Editor’s note: The headline of this story has been updated to correct the date. Tesla Inc. ( TSLA ) experienced a pre-market surge on Wednesday after news broke that its CEO, Elon Musk, is set to join Donald Trump’s team. The announcement was made by President-elect Trump on Tuesday. What Happened: At the time of writing on Wednesday, Tesla was...

08:49 AM EST, 11/13/2024 (MT Newswires) -- Comcast ( CMCSA ) said Wednesday that it has signed a $55 million joint investment agreement with the State of Indiana to provide high-speed internet service to rural communities. Under the contract, Comcast ( CMCSA ) will work with the Indiana Broadband Office and the Indiana Office of Community and Rural Affairs. The...

08:46 AM EST, 11/13/2024 (MT Newswires) -- Medicenna Therapeutics ( MDNAF ) , which lost 15% on the Toronto Stock Exchange on Tuesday, on Wednesday said it will present pre-clinical data on MDNA11 and IL-2 Superkines in glioblastoma models at the 29th Annual Meeting of the Society of Neuro-Oncology (SNO) in Houston at the end of the month. The company...